Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HGP1207 in PH with Systolic Heart Failure
NCT01913847Phase 3Unknown
- Sponsor
- Hanmi Pharmaceutical
- Start
- Sep 2013
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP-001 in Pulmonary Hypertension Associated With Systolic Heart Failure (PH-HFrEF), sponsored by Hanmi Pharmaceutical. Status: unknown.
02
Drugs
ASP-001
03
Conditions
Pulmonary Hypertension Associated With Systolic Heart Failure (PH-HFrEF)
Beyond the preview
Go deeper on NCT01913847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01913847.